Physician profile
Jabin Janoo
NPI 1871685834
$854.04
in general payments reported to CMS, 2019-2025
12 companies · $19.63 in 2025
The $19.63 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $106 · 2020: $17.45 · 2021: $105 · 2022: $223 · 2023: $223 · 2024: $160 · 2025: $19.63.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $309 · Education: $94.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $308.78 |
| Education | $94.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $251.08 | 2023-2024 | Veozah |
| Abbvie INC. | $214.40 | 2019-2023 | |
| Exeltis, USA INC. | $109.07 | 2022-2024 | Slynd |
| Aspira Women'S Health INC | $79.86 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $45.28 | 2019-2022 | |
| Pfizer INC. | $41.42 | 2024-2025 | |
| Scynexis, INC. | $25.49 | 2022 | |
| Ethicon US, LLC | $23.50 | 2022 | |
| Mylan Pharmaceuticals INC. | $20.30 | 2022 | |
| Vertical Pharmaceuticals, LLC | $15.32 | 2019 | |
| Amag Pharmaceuticals, INC. | $14.68 | 2019 | |
| Avion Pharmaceuticals | $13.64 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jabin Janoo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.